Eton Pharmaceuticals, Inc. (ETON) Stock Grade

About Eton Pharmaceuticals, Inc.'s fundamentals

Eton Pharmaceuticals is a specialty and generic drug manufacturer with a market capitalization of $455.0 million that has demonstrated strong top-line momentum, with revenue growing 104.9% year-over-year. Despite this rapid revenue expansion, the company operates at a net loss with a negative net margin of -5.8%, though it maintains positive free cash flow, suggesting that accounting losses do not currently reflect cash generation challenges. The company does not pay a dividend, and standard profitability metrics like price-to-earnings ratio and return on equity are not applicable given the net loss position.